Biotech and pharmaceutical companies and health care institutions are on the front lines of not only fighting COVID-19, but working to develop vaccines and therapies against the respiratory illness – often in unexpected ways.
A French consortium is stepping up previously announced plans for a saliva-based screening test to detect COVID-19, by joining up with medical laboratory and diagnostics group INOVIE.
CVS Health Corp. is expanding drive-through testing sites for COVID-19 to 350 locations in 14 U.S. states with an aim to open 1,000 sites nationwide by the end of May.
Randall Bolten – longtime Silicon Valley CFO, UC Berkeley Professor and author of the book Painting with Numbers: Presenting Financials and Other Numbers So People Will Understand You – released a research note on updated COVID-19 testing numbers. Broken down by country through May 10, 2020, the United States is not near the top of the pack.
As the mortality figures for COVID-19 continued to rise, people are wondering where they will stop. The actual death toll for COVID-19 will not be calculable for some time, but there are early indications that the mortality rate may be significantly lower than calculations of deaths per confirmed cases lead one to believe.
United Nations leaders called for a global effort to develop and distribute to all at affordable prices vaccines, treatments and testing kits against COVID-19.
Swiss pharma giant Roche joined the race to develop a test for COVID-19 antibodies in people who have been exposed to the disease.
Hospitalizations of people with the novel coronavirus fell for a second day in New York and the state would send ventilators to Michigan and Maryland, further signs some control is being gained on the outbreak, Governor Andrew Cuomo said on Wednesday.
The total number of people hospitalized in New York fell for the first time since the onset of the coronavirus outbreak, a further sign the state at the epicenter may be at the peak of its crisis, Governor Andrew Cuomo said on Tuesday.
French healthcare company Sanofi and U.S. start-up technology company Luminostics said they were joining up to work on developing a smartphone-based self-testing solution to see if someone has the COVID-19 coronavirus.